Detalles de la búsqueda
1.
Prescribed psychostimulants and other pro-cognitive medications in bipolar disorder: A systematic review and meta-analysis of recurrence of manic symptoms.
Bipolar Disord
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38670627
2.
A cross-sectional study of cognitive performance in bipolar disorder across the lifespan: the cog-BD project.
Psychol Med
; 53(13): 6316-6324, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36464659
3.
Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income country.
CNS Spectr
; 28(6): 710-718, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37160707
4.
Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis.
Int Rev Psychiatry
; 32(5-6): 477-490, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32498577
5.
Boxing as an Intervention in Mental Health: A Scoping Review.
Am J Lifestyle Med
; 17(4): 589-600, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37426738
6.
Protocol for a systematic review and meta-analysis of coordinate-based network mapping of brain structure in bipolar disorder across the lifespan.
BJPsych Open
; 9(6): e178, 2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37811544
7.
A systematic review on the effectiveness of dialectical behavior therapy for improving mood symptoms in bipolar disorders.
Int J Bipolar Disord
; 11(1): 6, 2023 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739574
8.
Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis.
J Affect Disord
; 339: 691-697, 2023 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467796
9.
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.
J Psychoactive Drugs
; : 1-17, 2023 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37615379
10.
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.
BJPsych Open
; 9(4): e134, 2023 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37489299
11.
Astrocytes in the Neuropathology of Bipolar Disorder: Review of Current Evidence.
Brain Sci
; 12(11)2022 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358439
12.
Brief App-Based Cognitive Behavioral Therapy for Anxiety Symptoms in Psychiatric Inpatients: Feasibility Randomized Controlled Trial.
JMIR Form Res
; 6(11): e38460, 2022 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36322113
13.
Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence.
Psychiatry Res
; 307: 114321, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34890909
14.
Metabolic function in patients with bipolar depression receiving anti-inflammatory agents: Findings from the MINDCARE study, a multicentre, randomised controlled trial.
J Affect Disord
; 299: 135-141, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798147
15.
The use of sequential pharmacotherapy for the treatment of acute major depression: a scoping review.
Expert Opin Pharmacother
; 22(8): 1005-1014, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33612048
16.
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence.
Life (Basel)
; 11(8)2021 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34440563
17.
Protocol for a systematic review and meta-analysis of the placebo response in treatment-resistant depression: comparison of multiple treatment modalities.
BMJ Open
; 11(2): e041349, 2021 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33593773
18.
Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-analysis.
JAMA Netw Open
; 4(9): e2125531, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34559231
19.
Metabolic variables associated with response to cognitive behavioural therapy for depression in females: A Canadian biomarker integration network for depression (CAN-BIND) study.
J Psychiatr Res
; 142: 321-327, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34419752
20.
The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.
J Affect Disord
; 294: 592-596, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332360